Neuroscience Company ElMindA Raises $28M

November 17, 2015 | Israeli neuroscience company ElMindA has raised $28 million in their Series C round. Investors in this round included Shanda Group, The Kraft Group, Wexford Capital, WR Hambrecht & Co, Palisade Capital Management, and OurCrowd. Found in 2006 by CTO Prof Amir Geva, ElMindA has developed a non-invasive method, using their Brain Network Activation (BNA™) platform, to analyze and visualize in high resolution the complex neuro-physiological interconnections of the human brain, capturing information on the composition, connectivity, synchronization and operation of brain networks. The company has raised $43 million to date, and the device received FDA approval for neurological disorders in 2014.